Dr. Srinagesh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
829 Suter Avenue
Palo Alto, CA 94303Phone+1 650-381-1991- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2020 - 2023
Icahn School of Medicine at Mount SinaiClass of 2020
Certifications & Licensure
CA State Medical License 2023 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- A Validated Risk Stratification That Incorporates MAGIC Biomarkers Predicts Long-Term Outcomes in Pediatric Patients with Acute GVHD.Kapoor, U., Muna Qayed, Urvi Kapoor, Scott Gillespie, Adrianna Westbrook, Paibel Aguayo-Hiraldo, Francis A Ayuk, Mina Aziz, Janna Baez, Hannah Choe, Zachariah DeFilipp...> ;Transplantation and Cellular Therapy. 2024 Mar 27
- 21 citationsBiomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin.Stephanie Gergoudis, Zachariah DeFilipp, Umut Ozbek, Karamjeet S. Sandhu, Aaron Etra, Hannah K. Choe, Carrie L. Kitko, Francis Ayuk, Mina Aziz, Janna Baez, Kaitlyn Ben...> ;Blood Advances. 2020 Dec 22
- 16 citationsDisease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant.Kapoor, U., Kapoor, U., Kapoor, U., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Leukemia. 2020 Feb 4
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
